Skip to search boxSkip to navigationSkip to main content

Targeting cholinergic system to modulate liver injury

  • Ravirajsinh N. Jadeja
    ,
  • Vikrant P. Rachakonda
    ,
  • Sandeep Khurana(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Peer-review

Abstract

Over the past few decades, evidence accumulated to indicate that parasympathetic innervation regulates liver injury and regeneration. Liver derives its parasympathetic input via vagus nerve. In animal models, vagus nerve stimulation and transection are frequently used to determine the impact of parasympathetic input on liver injury responses. Such strategies provide limited understanding of postneuronal mechanisms involved in the regulation of liver injury. The hepatic branch of vagus nerve releases acetylcholine (ACh), which activates muscarinic and nicotinic receptors in hepatocytes as well as non-parenchymal cells to modulate cellular functions. Moreover, vagus nerve releases other neurotransmitters such as vasoactive intestinal peptide (VIP), which also modulates liver injury responses and hemodynamics. Therefore, our understanding of the post-neuronal modulation of liver injury in models utilizing vagus nerve activity remains limited. Gene-silencing technologies and pharmacological manipulation of receptor activity have not only improved our understanding of the role of specific cholinergic receptors but also elucidated the role of various liver cell sub-populations in modulating liver injury response. With advent of organ- and cell-specific transgenic mice, our understanding of neural regulation of liver injury is likely to improve further. This review comprehensively provides current understanding of cholinergic regulation of liver injury, and points to potential therapeutic targets to treat liver injury.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 938-944 (7 pages)

Journal (Volume, Issue Number)

Current drug targets (Volume 19, Issue 8)

Publication milestones

  • Published - 2018

Publication status

Published - 2018

ISSN

1389-4501

Publication IDs

  • Scopus: 85052513522
  • PubMed: 28625139

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
SciVal
FWCI
0.05
SciVal
Author count
3
SciVal
citations
1
SciVal
Paper percentile
40

PlumX, opens in new tab

Citation count
7
Captures
6